Engine Biosciences (Engine), a Singapore- and Silicon Valley-based biotechnology company pioneering precision medicine for ...

Explore JANX's promising early data in prostate cancer immunotherapy. Understand market challenges, buyout rumors, and ...

Phase 2b study completed in amyotrophic lateral sclerosis (ALS) demonstrated lead asset PrimeC slows disease progression and functional d ...

I am thrilled to welcome Steve Hoerter to the Company’s Board as an independent director,” said Kent Hawryluk, President and Chief Executive Officer of MBX Biosciences. “As a seasoned leader within ...

The 2025 STAT Madness competition, a bracket-style celebration of biomedical research, stacked 64 entries against each other ...

ADMA Biologics, Inc. (Nasdaq: ADMA) ("ADMA” or the "Company”), an end-to-end commercial biopharmaceutical company dedicated ...

Overview of Smart Cancer Nanomedicine MarketThe Global Smart Cancer Nanomedicine Market is emerging as a revolutionary force ...

The dire wolf once roamed an American range that extended as far south as Venezuela and as far north as Canada, but not a ...

The longer I worked in the business, the more I realized how far these misaligned incentives and conflicts went.” ...

If you’ve ever experienced layoffs at your job, you know how stressful they can be, even under normal circumstances. But ...

Rein advanced the clinical development of its lead asset, LTI-03, and aims to initiate a Phase 2 trial for the treatment of idiopathic pulmonary f ...

Quibim, the global pioneer in imaging biomarkers for precision medicine, is pleased to announce the formation of its new Board of Directors. This strategic move aligns with Quibim's commitment to ...